Target intelligence / Profile preview

Transmembrane protein 237 (TMEM237)

Target
TMEM237
Molecular classification
Tetraspanin protein, Transition zone (TZ) ciliary protein, Transmembrane protein, Other (not a classical receptor, enzyme, transporter, or channel)
01

Overview

Transmembrane protein 237 (TMEM237) is a tetraspanin transmembrane protein that localizes to the ciliary transition zone (TZ), a key compartment at the base of primary cilia in eukaryotic cells[2][3][4][5]. TMEM237 is essential for the formation and maintenance of primary cilia, acting as part of a conserved module of transition zone proteins that regulate the structure and signaling capacity of this organelle[2][4]. Defects or mutations in TMEM237 cause Joubert syndrome 14 (JBTS14) and are implicated in other Joubert syndrome–related disorders due to disrupted ciliogenesis and deregulation of the Wnt signaling pathway[2][3][4]. TMEM237 also interacts with the intestinal riboflavin transporter RFVT-3, influencing the absorption and stability of vitamin B2 in intestinal epithelial cells, and its expression responds to inflammation and nutrient signaling[1][2]. TMEM237 is not a classical receptor, drug target, or enzyme; instead, it is a structural and regulatory ciliary protein with no currently identified direct drug interactions or use as a biomarker or therapeutic target for disease treatment.

Other names
ALS2CR4JBTS14Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 4amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 4ALS2CR4 proteinJBTS14 protein
02

Biological functions

Ciliogenesis (formation of cilia)Maintenance of ciliary transition zone structure and functionRegulation of Wnt signaling pathwayModulation of riboflavin transporter 3 (RFVT-3) stability and nutrient absorption
03

Disease associations

CiliopathiesJoubert syndrome 14 (JBTS14)Joubert syndrome–related disordersPotential involvement in amyotrophic lateral sclerosis regions by mapping, though not directly established as a cause

Beyond the preview

Go deeper on Transmembrane protein 237 (TMEM237).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protein 237 (TMEM237).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call